Advertisement

Allergen-Specific Immunotherapy (ASIT)

  • Vladimir V. Klimov
Chapter

Abstract

The reader can find the up-to-date information on allergens and their nomenclature, subcutaneous and sublingual methods of allergen-specific therapy (ASIT), mechanisms of action of ASIT, clinical efficacy, etc. There is an explanation why the ASIT as a modality of treatment for atopic allergic conditions is more important and be predominant in the near future.

Supplementary material

466144_1_En_11_MOESM1_ESM.mp3 (7.1 mb)
(MP3 7310 kb)

Bibliography

Reviews

  1. Bae JM, Choi YY, Park CO, Chung KY, Lee KH. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2013;132(1):110–7.  https://doi.org/10.1016/j.jaci.2013.02.044.CrossRefPubMedGoogle Scholar
  2. Ciprandi G, Marseglia GL, Riccardo Castagnoli R, et al. From IgE to clinical trials of allergic rhinitis. Expert Rev Clin Immunol. 2015;11(12):1321–33.  https://doi.org/10.1586/1744666X.2015.1086645.CrossRefPubMedGoogle Scholar
  3. Kim JM, Lin SY, Suarez-Cuervo C, Chelladurai Y, Ramanathan M, Segal JB, Erekosima N. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics. 2013;131(6):1–13.  https://doi.org/10.1542/peds.2013-0343.CrossRefGoogle Scholar
  4. Lin SY, Erekosima N, Kim JM, et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA. 2013;309(12):1278–88.  https://doi.org/10.1001/jama.2013.2049.CrossRefPubMedGoogle Scholar
  5. Thomas WR. Hierarchy and molecular properties of house dust mite allergens. Allergol Int. 2015;64:304–11.  https://doi.org/10.1016/j.alit.2015.05.004.CrossRefPubMedGoogle Scholar

Land Papers

  1. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J. 2015;8(17):1–12.  https://doi.org/10.1186/s40413-015-0063-2.CrossRefPubMedCentralGoogle Scholar
  2. Steveling-Klein EH. Allergen-specific immunotherapy. Euro Med J (EMJ). 2016;1(4):78–87.Google Scholar
  3. Tsai Y-G, Lin C-Y. Mechanism of regulatory T cells during allergen-specific Immunotherapy: from the past to future. J Allergy Ther. 2011;S7:1–4.  https://doi.org/10.4172/2155-6121.S7-005.CrossRefGoogle Scholar

Suggested Reading

  1. Aasbjerg K, Backer V. Steroids vs immunotherapy for allergic rhinitis: out with the old, in with the new. Expert Rev Clin Immunol. 2014;10(2):171–3.  https://doi.org/10.1586/1744666X.2014.875469.CrossRefPubMedGoogle Scholar
  2. Breiteneder H, Chapman MD. Allergen nomenclature. In: Lockey RF, Ledford DK, editors. Allergens and allergen immunotherapy: subcutaneous, sublingual and oral. 5th ed. Boca Raton: CRC Press, Taylor and Francis Group; 2014. p. 37–49.CrossRefGoogle Scholar
  3. Lundberg K, Rydnert F, Broos S, Andersson M, Greiff L, Lindstedt M. Allergen-specific immunotherapy alters the frequency, as well as the FcR and CLR expression profiles of human dendritic cell subsets. PLoS One. 2016;11(2):e0148838.  https://doi.org/10.1371/journal.pone.0148838.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Vladimir V. Klimov
    • 1
  1. 1.Clinical Immunology and Allergy DepartmentSiberian State Medical UniversityTomskRussia

Personalised recommendations